The NCCN 2014 Oncology Nursing Program at the NCCN 19th Annual Conference will provide the oncology nurse with comprehensive and clinically relevant information regarding the management of patients with cancer.

This NCCN Guidelines Insights report highlights treatment recommendations and updates specific to the management of patients with advanced non-clear cell carcinoma (non-ccRCC) in the 2014 version of the NCCN Guidelines for Kidney Cancer.

This recorded webcast, with interactive Q&A and patient-physician video case studies, will address the application of existing and emerging clinical research data to make evidence-based selection of first-line therapy for treatment of advanced renal cell carcinoma, optimal subsequent lines of

This live 75-minute webcast, with interactive Q&A and patient-physician video case studies, will address the application of existing and emerging clinical research data to make evidence-based selection of first-line therapy for treatment of advanced renal cell carcinoma, optimal subsequent li

The Westin Diplomat
Hollywood, Florida

This archived webinar series is designed to provide an in-depth analysis of the evidence and clinical decision-making that led to the development of the NCCN Guidelines® for Bladder, Kidney, and Prostate Cancers.

This archived webinar series is designed to provide an in-depth analysis of the evidence and clinical decision-making that led to the development of the NCCN Guidelines® for Bladder, Kidney, and Prostate Cancers.

This webinar series is designed to provide an in-depth analysis of the evidence and clinical decision-making that led to the development of the NCCN Guidelines® for Bladder, Kidney, and Prostate Cancers.

This webinar series is designed to provide an in-depth analysis of the evidence and clinical decision-making that led to the development of the NCCN Guidelines® for Bladder, Kidney, and Prostate Cancers.

This congress is a full-day educational program designed to provide an in-depth analysis of the evidence and clinical decision-making that led to the development of the NCCN Guidelines® for Bladder, Kidney, and Prostate Cancers.